AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026 
Erik Dowell was appointed as Chief Executive Officer of the Americas for InMode
IRVINE, Calif., Jan. 25, 2017 -- InMode/Invasix, a rapidly expanding professional aesthetic device company, announced Erik Dowell as Chief Executive Officer of the Americas. Mr. Dowell assumes leadership of the company’s North & South American sales, marketing, service, logistics and finance.
Moshe Mizrahy, CEO of InMode International Division, comments: “Erik is a veteran in the medical aesthetic industry and I am sure that he will bring with him many new ideas and lots of energy to continue our momentum in the market.”
Prior to that, Mr. Dowell served as President of the Americas with Syneron Candela since July 2013. With over 18 years of experience in the aesthetic light-based industry, Mr. Dowell held several positions within the company, including Vice President of the EMEA region (2010 - July 2013), Vice President of North America (2007-2010) and Regional Sales Director in North America (2003-2007). Prior to working for Syneron, Mr. Dowell worked for Coherent/Lumenis laser company from 1999 serving as the Western Regional Manager. Mr. Dowell received a B.A. in Business Management from University of Phoenix. He also completed the Executive Education Programs at the University of Chicago, and Harvard Business School (Harvard University).
About InMode/Invasix
InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser, and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode/Invasix technologies by visiting www.inmodemd.com.
Contact: Yang Phan Vice-President of Marketing for North America [email protected] | 1.855.411.2639 x3
